Trial
NCT06009653
Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Washington University School of Medicine
Collaborators
Eli Lilly and Company; National Institute on Minority Health and Health Disparities (NIMHD)
Condition
Obesity
Intervention
Standard Care
Why stopped
The study was discontinued prematurely for administrative reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-25